Erythropoietin in heart and vessels: Focus on transcription and signalling pathways

Journal of Thrombosis and Thrombolysis

Volumn 26, Issue 3, 2008, Pages 183-187

  Marzo, Francesca ^a   Lavorgna, Alberto ^a   Coluzzi, Giulio ^a   Santucci, Eleonora ^a   Tarantino, Federica ^a   Rio, Teresa ^a   Conti, Elena ^a   Autore, Camillo ^b   Agati, Luciano ^b   Andreotti, Felicita ^a  

^a FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Apoptosis; Erythropoietin; Erythropoietin receptor; Nitric oxide; Progenitor cells

Indexed keywords

CELL ADHESION MOLECULE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENDOTHELIN 1; ERYTHROPOIETIN; ERYTHROPOIETIN RECEPTOR; HYPOXIA INDUCIBLE FACTOR 1; JANUS KINASE 2; MITOGEN ACTIVATED PROTEIN KINASE; NITRIC OXIDE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN BCL 2; PROTEIN BCL XL; STAT5 PROTEIN; VON HIPPEL LINDAU PROTEIN;

ARTICLE; BIOAVAILABILITY; CARDIOVASCULAR SYSTEM; CELL MIGRATION; ENZYME ACTIVATION; GENETIC TRANSCRIPTION; HEART PROTECTION; HUMAN; LEUKOCYTE ADHERENCE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION; TISSUE DISTRIBUTION; UBIQUITINATION;

ANOXIA; APOPTOSIS; ENDOTHELIUM, VASCULAR; ERYTHROPOIETIN; FEMALE; HEART; HUMANS; MALE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; RECEPTORS, ERYTHROPOIETIN; SIGNAL TRANSDUCTION;

EID: 56349124221     PISSN: 09295305     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11239-008-0212-3     Document Type: Article

References (55)

1. Fisher JW (2003) Erythropoietin: Physiology and pharmacology update. Exp Biol Med (Maywood) 228:1-14
2. D'Andrea AD, Lodish HF, Wong GG (1989) Expression cloning of the murine erythropoietin receptor. Cell 57(2):277-285
3. Jones SS, D'Andrea AD, Haines LL, Wong GG (1990) Human erythropoietin receptor: Cloning, expression, and biologic characterization. Blood 75:31-35
4. Lipšic E, Schoemaker RG, van der Meer P et al (2006) Protective effects of erythropoietin in cardiac ischemia. J Am Coll Cardiol 48:2161-2167
5. Heeschen C, Aicher A, Lehmann R et al (2003) Erythropoietin is a potent physiologic stimulus for endothelial progenitor cell mobilization. Blood 102:1340-1346
6. Chong ZZ, Kang JQ, Maiese K (2002) Hematopoietic factor erythropoietin fosters neuroprotection through novel signal transduction cascades. J Cereb Flow Metab 22(5):503-514
7. 2 tension. Proc Natl Acad Sci USA 92:5510-5514
8. Rankin EB, Biju MP, Liu Q et al (2007) Hypoxia-inducible factor-2 (HIF-2) regulates hepatic erythropoietin in vivo. J Clin Invest 117:1068-1077
9. Scherer SW, Green ED (2004) Human chromosome 7 circa 2004: A model for structural and functional studies of the human genome. Hum Mol Genet 13:R303-R313
10. Lando D, Peet DJ, Whelan DA, Gorman JJ, Whitelaw ML (2002) Asparagine hydroxylation of the HIF transactivation domain a hypoxic switch. Science 295:858-861
11. Yasuda Y, Masuda S, Chikuma M, Inoue K, Nagao M, Sasaki R (1998) Estrogen-dependent production of erythropoietin in uterus and its implication in uterine angiogenesis. J Biol Chem 273(39):25381-25387
12. Stopka T, Zivny JH, Stopkova P et al (1998) Human hematopoietic progenitors express erythropoietin. Blood 91(10):3766-3772
13. David RB, Sjaastad OV, Blom AK et al (2005) Ontogeny of erythropoietin receptor mRNA expression in various tissues of the foetal and the neonatal pig. Domest Anim Endocrinol 29(3):556-563
14. Tan CC, Eckardt KU, Firth JD, Ratcliffe PJ (1992) Feedback modulation of renal and hepatic erythropoietin mRNA in response to graded anemia and hypoxia. Am J Physiol Renal Physiol 263: F474-F481
15. Sasaki R (2003) Pleiotropic functions of erythropoietin. Int Med 42(2):142-149
16. Junk AK, Mammis A, Savitz SI et al (2002) Erythropoietin administration protects retinal neurons from acute ischemia-reperfusion injury. Proc Natl Acad Sci USA 99(16):10659-10664
17. Parsa CJ, Kim J, Riel RU et al (2004) Cardioprotective effects of erythropoietin in the reperfused ischemic heart: A potential role for cardiac fibroblasts. J Biol Chem 279:20655-20662
18. van der Meer P, Voors AA, Lipsic E, van Gilst VH, van Veldhuisen DJ (2004) Erythropoietin in cardiovascular diseases. Eur Heart J 25:285-291
19. Depping R, Kawakami K, Ocker H et al (2005) Expression of the erythropoietin receptor in human heart. J Thorac Cardiovasc Surg 130:877-878
20. Anagnostou A, Liu Z, Steiner M et al (1994) Erythropoietin receptor mRNA expression in human endothelial cells. Proc Natl Acad Sci USA 91:3974-3978
21. Brines M, Cerami A (2006) Discovering erythropoietin's extra-hematopoietic functions: Biology and clinical promise. Kidney Int 70(2):246-250
22. Yamazaki T, Kanzaki M, Kamidono S, Fujisawa M (2004) Effect of erythropoietin on Leydig cell is associated with the activation of Stat5 pathway. Mol Cell Endocrinol 213:193-198
23. Ogilvie M, Xiaobing Y, Nicolas-Metral V et al (2000) Erythropoietin stimulates proliferation and interferes with differentiation of myoblasts. J Biol Chem 275:39754-39761
24. Fandrey J, Bunn HF (1993) In vivo and in vitro regulation of erythropoietin mRNA: Measurement by competitive polymerase chain reaction. Blood 81:617-623
25. Foster DJ, Moe OW, Hsia CCW (2004) Upregulation of erythropoietin receptor during postnatal and postpneumectomy lung growth. Am J Physiol Lung Cell Mol Physiol 287:L1107-L1115
26. Okada A, Kinoshita Y, Maekawa T et al (1996) Erytropoietin stimulates proliferation of rat-cultured gastric mucosal cells. Digestion 57(5):328-332
27. Feldman L, Wang Y, Rhim JS, Bhattacharya N, Loda M, Sytkowski AJ (2006) Erythropoietin stimulates growth and STAT5 phosphorylation in human prostate epithelial and prostate cancer cells. Prostate 66(2):135-145
28. Westenfelder C, Biddle DL, Baranowski R (1999) Human, rat and mouse kidney cells express functional erythropoietin receptors. Kidney Int 55:808-820
29. Wright GL, Hanlon P, Amin K et al (2004) Erythropoietin receptor expression in adult rat cardiomyocytes is associated with an acute cardioprotective effect for recombinant erythropoietin during ischemia-reperfusion injury. FASEB 18(9):1031-1033
30. D'Andrea AD, Zon L (1990) Erythropoietin receptor. Subunit, structure and activation. J Clin Invest 86:681-687
31. Farrell F, Lee A (2004) The erythropoietin receptor and its expression in tumor cells and other tissues. Oncologist 9:18-30
32. Urao N, Okigaki M, Yamada H et al (2006) Erythropoietin-mobilized endothelial progenitors enhance reendothelialization via Akt-endothelial nitric oxide synthase activation and prevent neointimal hyperplasia. Circ Res 98(11):1341-1343
33. Vanhoutte PM (1988) The endothelium modulator of vascular smooth-muscle tone. N Engl J Med 319:512-513
34. Vallance P, Collier J, Moncada S (1989) Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man. Lancet 2:997-1000
35. Radomski MW, Palmer RM, Moncada S (1987) Endogenous nitric oxide inhibits human platelet adhesion to vascular endhotelium. Lancet 2:1057-1058
36. Lindenblatt N, Menger MD, Klar E, Vollmar B (2007) Darbepoetin-alpha does not promote microvascular thrombus formation in mice: Role of eNOS-dependent protection through platelet and endothelial cell deactivation. Arterioscler Thromb Vasc Biol 27(5):1191-1198
37. Dubey RK, Jackson EK, Luscher TF (1995) Nitric oxide inhibits angiotensin II-induced migration of rat aortic smooth muscle cells. Role of cyclic-nucleotides and angiotensin 1 receptors. J Clin Invest 96(1):141-149
38. Kubes P, Suzuki M, Granger DN (1991) Nitric oxide: An endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci USA 88:4651-4655
39. Tharaux PL, Chatziantoniou C, Casellas D et al (1999) Vascular endothelin-1 gene expression and synthesis and effect on renal type I collagen synthesis and nephroangiosclerosis during nitric oxide synthase inhibition in rats. Circulation 99(16):2185-2191
40. De Caterina R, Libby P, Peng HB et al (1995) Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J Clin Invest 96:60-68
41. Palmer RM, Ashton DS, Moncada S (1998) Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature 333:664-666
42. Seddon M, Shah AM, Casadei B (2007) Cardiomyocytes as effectors of nitric oxide signalling. Cardiovasc Res 75(2):315-326
43. Banerjee D, Rodriguez M, Nag M, Adamson JW (2000) Exposure of endothelial cells to recombinant human erythropoietin induces nitric oxide synthase activity. Kidney Int 57(5):1895-1904
44. Beleslin-Cokic BB, Cokic VP, Yu X, Weksler BB, Schechter AN, Noguchi CT (2004) Erythropoietin and hypoxia stimulate erythropoietin receptor and nitric oxide production by endothelial cells. Blood 104:2073-2080
45. Ruschitzka FT, Wenger RH, Stallmach T et al (2000) Nitric oxide prevents cardiovascular disease and determines survival in polyglobulic mice overexpressing erythropoietin. Proc Natl Acad Sci USA 97(21):11609-11613
46. Kanbay M, Akcay A, Delibasi T et al (2007) Comparison of darbepoetin alfa and epoetin alfa on serum endothelin level and blood pressure. Adv Ther 24(2):346-352
47. Quaschning T, Ruschitzka F, Stallmach T et al (2003) Erythropoietin-induced excessive erythrocytosis activates the tissue endothelin system in mice. FASEB J 17(2):259-261
48. Ruschitzka FT, Wenger RH, Stallmach T et al (2000) Nitric oxide prevents cardiovascular disease and determines survival in polyglobulic mice overexpressing erythropoietin. Proc Natl Acad Sci USA 97(21):11609-11613
49. Hiasa K, Ishibashi M, Ohtani K et al (2004) Gene transfer of stromal cell-derived factor-1alpha enhances ischemic vasculogenesis and angiogenesis via vascular endothelial growth factor/endothelial nitric oxide synthase-related pathway: Next-generation chemokine therapy for therapeutic neovascularization. Circulation 109(20):2454-2461
50. Aicher A, Heeschen C, Mildner-Rihm C et al (2003) Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells. Nat Med 9(11):1370-1376
51. Choi JH, KiKuh W et al (2004) Decreased number and impaired angiogenic function of endothelial progenitor cells in patients with chronic renal failure. Arterioscl Thromb Vasc Biol 24(7):1246-1252
52. Coluzzi G, Santucci E, Marzo F, Andreotti F (2007) Asymmetric dimethylarginine and impaired cardiovascular healing. J Thromb Thrombolysis. Dec 10 [Epub ahead of print]
53. Siren A, Fratelli M, Brines ML et al (2001) Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress. Proc Natl Acad Sci USA 98:4044-4049
54. Ehrenreich H, Hasselblatt M, Dembowski C et al (2002) Erythropoietin therapy for acute stroke is both safe and beneficial. Mol Med 8(8):495-505
55. Burger D, Lei M, Geoghegan-Morphet N et al (2006) Erythropoietin protects cardiomyocytes from apoptosis via up-regulation of endothelial nitric oxide synthase. Cardiovasc Res 72(1):51-59